102 related articles for article (PubMed ID: 1444821)
1. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
Katagiri T
Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
[TBL] [Abstract][Full Text] [Related]
2. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
[TBL] [Abstract][Full Text] [Related]
3. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
4. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
5. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
6. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
Sagawa A; Abdou NI
J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
[TBL] [Abstract][Full Text] [Related]
7. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
Perl A; Gonzalez-Cabello R; Gergely P
J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
[TBL] [Abstract][Full Text] [Related]
8. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
9. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
[TBL] [Abstract][Full Text] [Related]
10. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.
Alcocer-Varela J; Laffon A; Alarcón-Segovia D
Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371
[TBL] [Abstract][Full Text] [Related]
11. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
14. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
[TBL] [Abstract][Full Text] [Related]
15. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
16. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.
Niwa Y; Sakane T; Shingu M; Yokoyama M
J Clin Lab Immunol; 1984 May; 14(1):35-43. PubMed ID: 6086929
[TBL] [Abstract][Full Text] [Related]
17. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
Lavalle C; Alcocer J; Gudiño J; Fraga A
Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
[TBL] [Abstract][Full Text] [Related]
18. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
19. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.
Victorino RM; Ryan P; Hughes GR; Hodgson HJ
Clin Exp Immunol; 1982 Apr; 48(1):121-8. PubMed ID: 6211313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]